Enzon Pharmaceuticals Inc (OTCMKTS:ENZN) shares dropped 2.6% on Monday . The company traded as low as $0.22 and last traded at $0.24. Approximately 7,600 shares traded hands during trading, a decline of 75% from the average daily volume of 30,743 shares. The stock had previously closed at $0.25.

The firm’s fifty day simple moving average is $0.23.

ILLEGAL ACTIVITY NOTICE: “Enzon Pharmaceuticals (OTCMKTS:ENZN) Shares Down 2.6%” was first posted by Watch List News and is the property of of Watch List News. If you are accessing this piece on another publication, it was copied illegally and republished in violation of international copyright laws. The correct version of this piece can be viewed at https://www.watchlistnews.com/enzon-pharmaceuticals-otcmktsenzn-shares-down-2-6/3044306.html.

Enzon Pharmaceuticals Company Profile (OTCMKTS:ENZN)

Enzon Pharmaceuticals, Inc, together with its subsidiaries, engages in licensing drug products. Its marketed drug products include PegIntron for use in the treatment of chronic hepatitis C; and Sylatron for use in the treatment of melanoma disease. The company was founded in 1981 and is headquartered in Cranford, New Jersey.

Read More: The components of the Stochastic Momentum Index

Receive News & Ratings for Enzon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enzon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.